Meet With Avance Clinical At ASCO 2025 In Chicago
Visit Us At Booth #36155
Avance Clinical will attend and host a booth at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting, scheduled from May 30 to June 3, 2025, at McCormick Place in Chicago, Illinois. This premier event brings together oncology professionals from around the world to connect, collaborate, and inspire advancements in cancer care.
Our team of experts will be available to discuss how Avance Clinical can support your oncology clinical trial needs. With over three decades of experience in biotech drug development, we have conducted more than 65 oncology trials in the past five years, demonstrating significant clinical operations expertise in this high-growth sector.
Led by Avance Clinical’s Chief Scientific Officer, Gabriel Kremmidiotis, our team has adopted a solution-oriented, flexible, and agile approach in service delivery, which is particularly applicable and of significance in managing oncology clinical trial. This strategy enables us to adeptly handle the unique demands of clinical trials in cancer research, integrating state-of-the-art technologies and methodologies to enhance trial design and execution while responding with precision to the intricacies of this field.
We specialize in a wide range of oncology indications
Solid Tumors
Sarcomas
- Ewing’s Sarcoma
Brain Tumors
- Glioblastoma Multiforme (GBM)
Head and Neck Cancers
Liver Cancers
- Hepatocellular Carcinoma (HCC)
Skin Cancers
- Melanoma
Lung Cancers
- Non-Small Cell Lung Cancer
Other Solid Tumors
- Renal Cancer
- Breast Cancer
- Colorectal Cancer
- Ovarian Cancer
- Prostate Cancer
Genetic/Molecular Subtypes (e.g. p53 Mutations)
Hematologic (Blood) Cancers
Leukemias
- Acute Lymphoblastic Leukemia (ALL)
- Chronic Lymphocytic Leukemia
Lymphomas
- B-cell Non-Hodgkin’s Lymphoma
- Hodgkin’s Lymphoma
Other Hematological Malignancies
- Multiple Myeloma
- Myelofibrosis
- Myeloproliferative Neoplasms
Our comprehensive services are designed to accelerate oncology projects, particularly through the early phases of clinical development ensuring high-quality data and efficient trial execution. Avance Clinical offers its expertise from preclinical through to Late phase studies.
Discover more about key services:
Join us at ASCO 2025 to explore how Avance Clinical’s expertise can advance your oncology drug development journey. We look forward to connecting with you in Chicago.
Source: Avance Clinical